CYNATA THERAPEUTICS LIMITED
ASX:CYP
Biotechnology
Live Capital Raise
CYNATA THERAPEUTICS LIMITED has not announced a capital raise, but we are collating interest in any future round. Pledge your support and we will let the company know of your interest.
Demand Registered for Next Raise
< $50k
Investors Interested in Next Raise
< 10
Capital Raise History
Company Overview
Cynata Therapeutics Limited (CYP) is an Australian clinical-stage stem cell and regenerative medicine company developing therapies based on its proprietary CymerusA stem cell technology platform. Former Names Senevens International Limited (SVN), 5/12/2008; Eco Quest Limited (ECQ), 15/11/2013.
Type
Listed Company
GICS Sub-industry
Biotechnology
Head Office
Level 3/62 Lygon St, Carlton VIC 3053, Australia
Website
Biotechnology
Health Care
Quarterly Cash Flows
The numbers below are derived from quarterly cash flow reports provided by the company. Fresh Equities does not guarantee that the information provided is accurate, you can read the associated report by clicking read more for the quarter. Always do your own research and do not rely on the information provided here as your only source of research.
Directors
Announcements, Interviews, News, and Presentations
More Companies Raising Right Now
Other Companies You Might Like
Archive
Support
This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by Fresh Equities Pty Ltd, its representatives or any other third party regardless of whether such security, product or service is referenced on this website.